Stock Groups

Oxford Nanopore eyes $4.7 billion market value in London debut By Reuters

by Mike Robinson

[ad_1]

© Reuters.

(Reuters) – Oxford Nanopore Technologies, a biotech company with a market cap of approximately 3.4 billion pounds ($4.65 trillion), will trade in London starting Thursday at a price of 425 pence each share.

It is a company that specialises in DNA sequencing. The company also provides quick COVID-19 testing to Britain’s health service. It decided to set its IPO prices at the high end of an earlier range.

($1 = 0.7311 pounds)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. CFDs are stocks, futures, indexes or Forex. The prices of Forex and CFDs are not supplied by exchanges. However, market makers provide accurate prices. This means that prices might not reflect the market. Fusion Media does not accept any liability for trade losses you may incur due to the use of these data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. You should be aware of all the potential risks and expenses associated with trading in the financial market. It is among the most dangerous investment types.



[ad_2]